GE HealthCare Technologies (GEHC) Liabilities and Shareholders Equity (2022 - 2026)

GE HealthCare Technologies (GEHC) reported Liabilities and Shareholders Equity of $37.1 billion for Q1 2026, up 10.54% on a YoY basis from $33.6 billion in Q1 2025, and up 0.59% quarter-over-quarter from $36.9 billion in Q4 2025.

GE HealthCare Technologies (GEHC) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends

GE HealthCare Technologies has reported Liabilities and Shareholders Equity for 5 years, with the latest figure at $37.1 billion in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 10.54% year-over-year to $37.1 billion; the trailing twelve-month figure through Mar 2026 stood at $145.7 billion (up 10.03% YoY), and the FY2025 full-year result was $36.9 billion, up 11.54% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $37.1 billion, up from $36.9 billion in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $37.1 billion in Q1 2026, with the low at $27.5 billion in Q4 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $33.4 billion across 5 years, with a median of $32.9 billion in 2023.
  • Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity increased 17.85% — and 2024, when it dropped 1.42%.
  • GE HealthCare Technologies' Liabilities and Shareholders Equity stood at $27.5 billion in 2022, then advanced by 17.85% to $32.5 billion in 2023, then advanced by 1.96% to $33.1 billion in 2024, then rose by 11.54% to $36.9 billion in 2025, then advanced by 0.59% to $37.1 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $37.1 billion (Q1 2026), $36.9 billion (Q4 2025), and $36.1 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 110.43 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 46.29 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 37.13 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 10.74 Bn
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn 22.72 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 37.13 Bn
Dec 31, 2025 36.91 Bn
Sep 30, 2025 36.13 Bn
Jun 30, 2025 35.50 Bn
Mar 31, 2025 33.59 Bn
Dec 31, 2024 33.09 Bn
Sep 30, 2024 33.86 Bn
Jun 30, 2024 31.85 Bn
Mar 31, 2024 32.21 Bn
Dec 31, 2023 32.45 Bn
Sep 30, 2023 32.38 Bn
Jun 30, 2023 32.31 Bn
Mar 31, 2023 32.64 Bn
Dec 31, 2022 27.54 Bn